Prospective Cohort Study and Emulated Target Trial to Estimate the Safety and Effectiveness of MVA-BN vaccination against MPXV infection in at-risk individuals in Germany (SEMVAc/TEMVAc)

15/12/2022
20/09/2024
EU PAS number:
EUPAS50093
Study
Finalised

ENCePP Code of conduct

No
Data sources

Data source(s)

Data sources (types)

Other

Data sources (types), other

Prospective patient-based data collection in infectious disease clinics (SEMVAc) and retrospective data abstraction from EHRs in a subset of the SEMVAc clinics (TEMVAc)
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Yes

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

Not applicable